1. Introduction
Potato juice (PJ) can be simply defined as a liquid fraction of potato tubers. It is a complex mixture that contains approximately 6% of dry mass. The main fractions of potato juice are proteinaceous compounds (amino acids, peptides, and proteins) of high nutritional value. Apart from them, PJ also contains other organic compounds, such as sugars, carboxylic acids, or vitamins, as well as approximately 1% of minerals. On an industrial scale, PJ is generated by the production of starch. This side stream was initially considered a troublesome waste and the driving force behind the development of the technology of its valorization for environmental sakes [
1,
2]. Currently, due to the huge increase in interest in new, vegetable sources of protein, there has been significant technological progress in processing PJ. Moreover, starch-producing companies consider the production of potato protein for human nutrition a task as important as the production of starch itself [
3,
4,
5,
6,
7]. However, the value of PJ is not limited to human nutrition. Current literature data indicate various biological activities, including antioxidant, antimicrobial, anti-inflammatory, anticancer, antiobesity, antidiabetic, antihyperlipidemic, and antihypertensive effects [
7,
8,
9,
10,
11,
12,
13,
14,
15,
16]. The high medicinal potential of PJ is also supported by the long-standing tradition in European folk medicine of using this substance for the treatment of gastric ulcers [
17,
18]. As the diagnosis and differentiation of diseases in folk medicine were extremely limited, it is currently difficult to refer to what types of diseases were treated with potato juice. It was probably a series of diseases of various etiology, including neoplastic changes.
PJ contains a lot of substances with biological activity. These are both proteins or peptides (mainly protease inhibitors), as well as a lot of various non-proteinaceous substances. Among the latter, vitamin C and the vitamin B complex should be mentioned, as well as polyphenols, mainly: chlorogenic and caffeic acids, lutein, violaxanthin, zeaxanthin, antheraxanthin, and β-carotene [
19,
20]. Special attention should be paid to glycoalkaloids (GAs), mainly α-chaconine and α-solanine, which are commonly known for their harmful effects on the human body. The maximum level of glycoalkaloids in the potato protein preparations introduced in the European market has been set at 150 mg per 1 kg [
21] to protect consumers’ health against poisoning [
22]. Nevertheless, literature data suggests a huge medicinal potential of gas, especially in cancer treatment [
23].
In vitro studies have demonstrated the antiproliferative effect of α-solanine against different human tumor cell lines: HepG2 (liver), AGS and KATO III (stomach), HT-29 (colon), Panc-1 and SW1990 (pancreas), U937 (lymphoma), Jurkat (leukemia), A2058 (melanoma), PC-3 and DU145 (prostate), RL95-2 (endometrium), EC9706 (esophagus) and HeLa (cervix) [
23,
24,
25]. What is important, it was shown that although α-solanine can be toxic to normal cells at higher doses, it may reveal therapeutic effects against cancer cells at non-toxic concentrations [
26]. These observations were also verified in in vivo studies [
27,
28]. Similar results were also obtained in
in vitro studies with α-chaconine using colon (HT-29), liver (HepG2), cervix (HeLa), lymphoma (U937), and stomach cell lines [
24,
25,
29]. What is important is that the simultaneous use of both GAs may cause a synergistic effect [
29].
In vitro studies have also shown the antitumor activity of other components of potato juice, including polyphenols (mainly chlorogenic acid) and protease inhibitors (one of the juice’s protein fractions) [
30,
31,
32].
This above-presented short description of the current knowledge regarding the medicinal potential of potato juice points to the possibility of using PJ or its components for cancer treatment or at least to support the treatment by diet fortification. Attempts to use potato juice for the production of functional foods have already been undertaken, and their therapeutic use has been demonstrated in short, preliminary clinical trials [
33,
34,
35,
36]. A barrier to the wider use of PJ and its processing products in supporting cancer treatment is the lack of knowledge of the interactions of individual PJ components. In particular, it is not known whether the individual components of the PJ show a synergistic effect or, on the contrary, they have an antagonistic effect. The changes that PJ undergoes during digestion and how this affects its biological activity, as well as the effect of the processing of PJ on its bioactivity, are also not known.
Given the aforementioned, the foundation of our study was to verify whether the bioactive compounds present in PJ show mutual interaction in the context of cytotoxicity. Thus, the work aimed to establish the antiproliferative effect of gastrointestinal digested PJ and the products of its processing. Fresh PJs derived from three different potato varieties, industrial side stream resulted from starch production, partially deproteinated PJ derived from feed protein production line, and three different potato protein preparations subjected to digestion in the artificial gastrointestinal tract were used in this study.
2. Materials and Methods
2.1. Experimental Materials
Fresh juices from potatoes of 3 varieties (‘Agata’, ‘Queen Anne’ and ‘Vivaldi’, denoted as ‘APJ’, ‘QAPJ’ and ‘VPJ’, respectively) were obtained by thoroughly washing and peeling the tubers, and then squeezing the juice using a VitaJuice 4 juicer (Robert Bosch GmbH, Gerlingen-Schillerhöhe, Germany). Each time, the juice obtained was centrifuged at 4 °C (3000× g) in order to separate the starch remaining in the juice, and then the juice was decanted, frozen, and freeze-dried.
Industrial potato juice (IPJ) and deproteinized potato juice water (DPJ) were collected from PPZ Trzemeszno S.A. (Trzemeszno, Poland) as a side stream of the potato starch extraction process.
Moreover, the research used potato juice protein concentrate (MPP), obtained according to the membrane method described in detail earlier [
6], commercial potato protein Solanic
®200 (NPP) purchased from Avebe (Veendam, The Netherlands), and feed potato protein (FPP) obtained from PPZ Trzemeszno S.A. (Trzemeszno, Poland).
α-Solanine and α-chaconine were purchased from Phytolab GmbH & Co. KG (Vestenbergsgreuth, Germany). Pork pepsin, porcine pancreatin, bile salt, caffeic, chlorogenic, ferulic, and gallic acids were purchased from Sigma-Aldrich (Steinheim, Germany). All other reagents, purity min. HPLC grades were purchased from Merck Life Science (Darmstadt, Germany).
2.2. Digestion Process
The
in vitro gastrointestinal digestion procedure was performed with a simplified methodology on the basis of the method previously described in detail by Olejnik et al. [
37]. In short, the digestion process of analyzed samples was performed in a glass bioreactor, which was thermally stable, and the reactions were carried out at 37 °C. Samples for further analyses were prepared by taking 10 g of freeze-dried experimental products and dissolving them in demineralized water to a volume of 100 mL. Independent products of digestion were obtained after digestion in the stomach (denoted as a suffix -G) and also after complete gastrointestinal digestion (denoted as -GI). Stomach stage: with 1 M HCl, the pH of the digested mixture was lowered to 2.0, and then a solution of pork pepsin in 0.1 M HCl was added to obtain a concentration of 1.92 mg pepsin/mL of the mixture. The process was carried out for 2 h with constant stirring. Intestine stage: After a 2-h gastric digestion, the pH of the mixture was raised to 7.0 with 2M NaHCO
3 and then supplemented with porcine pancreatin (0.4 mg/mL) and bile salt (2.4 mg/mL). Intestinal digestion was carried out for 2.5 h. All digestion samples were frozen at −80 °C and then lyophilized. In order to perform the quantitative analysis, the volumes of the digested mixtures were monitored at all stages of the gastrointestinal tract. The digestion process described above was performed in triplicate using the same experimental material.
2.3. GAs Content
The isolation and purification of the GAs from the analyzed samples were carried out according to the procedure described in detail previously [
38]. In short, lyophilized samples were extracted with 5% acetic acid, shaken for 15 min, and then centrifuged (10,000×
g, 15 min, 4 °C). The GAs were isolated from the supernatant obtained using solid phase extraction (SPE) cartridges (HLB Oasis 1cc 30 mg, Waters Corporation, Milford, MA, USA), eluting with methanol with formic acid (0.1%
v/v). The eluate was filtered (0.22 µm) before the analysis.
The quantitative and qualitative determination of α-solanine and α-chaconine was performed using the chromatographic system UltiMate 3000 RSLC (Dionex™, Thermo Scientific Inc., Waltham, MA, USA) coupled to an API 4000 QTRAP triple quadrupole mass spectrometer with electrospray ionization (ESI) (from AB Sciex, Foster City, CA, USA) in positive ionization mode (UHPLC–MS/MS). Chromatographic separation was performed on a Kinetex 1.7 µm C18 column (100 mm × 2.1 mm I.D.) from Phenomenex Inc., Torrance, CA, USA. 0.1% formic acid (A) and acetonitrile (B) were used as the mobile phase. Elution was performed using a gradient: 25% B at 0 min, 32% at 3 min, increased to 100% B in 3 min, and held for 0.5 min. The flow rate was 0.20 mL/min. The column temperature was maintained at 35 °C, and the injection volume was 10.0 μL. A post-run time was set at 4.0 min for column equilibration before the next injection. The operating conditions for mass spectrometry for α-solanine and α-chaconine were as follows: curtain gas 10 psi, nebulizer gas, and auxiliary gas 40 psi, source temperature 600 °C, ion spray voltage 5500 V, and collision gas set to medium. Quantitative analysis of the compounds was performed in multiple reaction monitoring (MRM) mode, for analytes were chosen one transition of the protonated molecular ion and their respective ion product. The first MRM transition was used to quantitate; the second was used as confirmation. These transitions (m/z) with associated decluttering potentials (V) and collision energies (V) were: α-solanine 869 → 98, 181, 115; 869 → 398, 181, 95 and α-chaconine 852.6 → 98, 201, 119; 852.6 →706, 201, 97.
2.4. Polyphenols Profile
Extraction of the polyphenolic compounds was done using 80% methanol. The methanol solution was added to 150 mg of the lyophilized samples to obtain a volume of 1.5 mL. The samples prepared in this way were shaken for 20 min, centrifuged (10,000× g, 10 min, 4 °C), and the obtained supernatants were filtered through a 0.22 µm filter.
The same LC-MS/MS system, as for
α-solanine and
α-chaconine determination, was used for the determination of phenolic acids (PAs), including caffeic (CaA), chlorogenic (ChA), and ferulic (FA) acids, according to the method described by Cybulska et al. [
39]. Chromatographic separation was achieved on the analytical column Luna 3 µm C18 (150 mm × 2.0 mm I.D., Phenomenex Inc., Torrance, CA, USA) using 5 mM ammonium acetate in water (A) and methanol (B) as mobile phase in a gradient mode of elution: 0 min 50% B, 2.5 min 50% B, 3 min 100% B, and 3.5 min 100% B. The flow rate was 0.2 mL/min, and the injection volume was 5.0 μL. MS-MS detection was performed in a negative ionization mode with the ion transitions (
m/z) with associated decluttering potential (V) and collision energies (V) were: for caffeic acid 179 → 135, −51, −22; 179 → 106, −51, −32, for chlorogenic acid: 353 → 85, −65, −24; 353 → 191, −65, −64, for ferulic acid: 193 → 134, −55, −20; 193 → 178, −55, −18, and for gallic acid: 169 → 125, −55, −22; 169 → 79, −32, −5. The analyte was detected using the following settings for the ion source and mass spectrometer: curtain gas 10 psi, nebulizer gas 40 psi, auxiliary gas 40 psi, temperature 400 °C, ion spray voltage −4500 V, and collision gas set to medium. All compounds were quantified in extracts using the standard addition method.
2.5. In Vitro Study
2.5.1. Cell Cultures
The cytotoxic potential of potato GAs (α-chaconine and α-solanine), PAs (CA, ChA, FA), and digested PJ and products of its processing (PDPJPs) were determined in cancer and normal human cells derived from the digestive system. The normal small intestine hIEC-6 (ATCC® CRL-3266™) and colon mucosa CCD 841 CoN (ATCC® CRL-179™) cell lines, gastric carcinoma AGS (ATCC® CRL-1739™) and Hs 746T (ATCC® HTB-135™) cell lines, colorectal adenocarcinoma Caco-2 (ATCC® HTB-37™) and HT-29 (ATCC® HTB-38™) cell lines were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cell lines were cultured under standard conditions recommended as optimal by ATCC.
2.5.2. Cytotoxicity Assay
In the cytotoxicity tests, the cells were grown in 96-well plates at an initial density of 1.5 × 10
4 cells/cm
2. The 24-h cultures were treated with GAs (1–20 µM), PAs (10–200 µM), and PDPJPs (0.1–20 mg/mL) for 48 h. The range of GAs doses was established considering GAs solubility and cytotoxicity to all cell cultures tested. GAs dose range included non-toxic and highly toxic (lethal) GAs concentrations in human normal and cancer cell lines. In the cytotoxicity analysis of potato phenolic acids, concentrations up to 200 μM were applied due to their physiological relevance and contents in PJ products. DPJP concentration range was established to allow modeling of the cell response-dose curve and calculation of half maximum cytotoxic doses. The exposition time, which should not be less than the time needed to double the cell population, was optimized for all cell lines used in the experiments. As the proliferation rate of the cells derived from normal tissues was significantly lower than that of cells isolated from tumor tissues and the doubling population time determined in normal intestinal cell cultures exceeded 24 h, the treatment time was established at 48 h. The effect of the potato compounds and products on cell viability and metabolic activity was evaluated with the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (Sigma–Aldrich, Steinheim, Germany) test according to the previously described procedure [
40]. This test was chosen because of its high sensitivity and repeatability. Preliminary experiments showed that the MTT test was more sensitive and accurate than alternative cytotoxicity assays, including the Sulforhodamine B and Alamarblue™ tests. After normal and cancer cell treatment, the MTT solution (5 mg MTT/mL) was added to each well to obtain a concentration of 0.5 mg MTT/mL. The cultures were incubated at standard culture conditions for 3 h, and then formazan crystals were extracted with isopropanol for 20 min at room temperature. The absorbance was measured at 570 nm and 690 nm using a Tecan M200 Infinite microplate reader (Tecan Group Ltd., Männedorf, Switzerland). Based on the MTT results, dose-response curves were plotted, and then cytotoxic doses of the analyzed compounds were calculated.
2.6. Statistical Analysis
The experimental data, presented as mean ± SD, was studied using a one-way analysis of variance, and the Tukey post hoc test was used to determine statistically homogenous subsets at α = 0.05. The Pearson correlation coefficient was calculated for GAs content in products before and after gastric and gastrointestinal digestion. Principal component analysis was performed based on a correlation matrix. Clustering was performed based on Ward’s method, and Euclidean distance was used as a measure of similarity. Statistical analyses were performed using Statistica 13.3 software (Dell Software Inc., Round Rock, TX, USA).
4. Limitations and Future Perspectives
The main goal of our work was to verify which bioactive components of PJ show antiproliferative activity. Eight different materials were studied. They include three samples of fresh juice derived from edible potato varieties; fresh PJ being a side stream from starch production line; a deproteinized fraction of PJ; feed potato protein obtained by acid-thermal coagulation, potato protein prepared by employing membrane technology and commercial potato protein designed for human nutrition. We examined the cytotoxicity of solanine and chaconine as well as the chlorogenic, ferulic, and caffeic acids. We also analyzed the bioavailability of the bioactive substances mentioned above after gastric and gastrointestinal digestion. Moreover, the cytotoxicity of PJ products subjected to gastric digestion was studied against AGS and Hs746T cell lines. Likewise, the cytotoxicity against the HT-29, Caco-2, hIEC-6, and CCD 481 CoN cell lines was analyzed with gastrointestinally-digested products. We have shown that the analyzed phenolic acids, including chlorogenic acid, do not show cytotoxicity to the cell lines used in the study. In contrast, both glycoalkaloids reveal significant cytotoxicity, which allowed for the calculation of IC50 against all cell lines. In all cases, chaconine was characterized by higher cytotoxicity than solanine.
Statistical analysis of the obtained results showed that fresh juices and, more generally, preparations with a low content of GAs are similar to each other in terms of IC
50 values. In contrast, the similarity of other preparations is based on the content of solanine and chaconine. This suggested that the cytotoxicity of different materials is also determined by other factors, not only the content of the GAs itself. Therefore, the concept of the effective values of IC
50 of GAs was created. This value describes the IC
50 per unit mass of the total GAs contained in the sample. The calculation of the effective IC
50 values for all analyzed samples and their comparison with the IC
50 values of the pure GAs proved the synergistic effect of bioactive substances contained in PJ and the products of its processing. Our research does not make it possible to determine which substances are responsible for this synergism. One of the main questions is whether the ratio of solanine to chaconine is significant, and if so, what is its optimal value? Another important issue is which of the other bioactive substances influence the synergistic effect. Is it not only ChA but also other phenolic acids? What is the importance of vitamins? What is the molecular mechanism of these interactions? Could cellular and molecular pathways be mediated by reactive oxygen species (ROS) induced by DPJPs? The data reported in the literature indicates ROS involvement in antiproliferative PJ activity [
50]. However, our study does not provide evidence to support this conception.
Interesting data obtained in this research are great inspiration for further detailed studies on molecular and cellular pathways via which fresh potato juice and products of its processing may interact with cancer cell proliferation and apoptosis. The promising findings also concern more potent inhibitory effects targeting cancer cells than normal colon mucosa cells. Unfortunately, more specific conclusions about the mechanisms of action of potato juice bioactive compounds cannot be drawn based on the scope of the experimental work presented and the analytical methods employed.
In future studies, it will be important to analyze the cell cycle progression and apoptosis or autophagy induction in the normal and neoplastic cells treated with physiologically relevant doses of potato juice bioactive constituents as single compounds, as combination mixtures, and as potato juice products. Future antiproliferative experiments should include cell cycle distribution by iodine propidine cell staining and flow cytometry measurement, as well as apoptosis analysis, including microscopic apoptosis detection preceding the analysis of caspase 3/7 activity, Annexin-V/PI staining assay, Tunnel assay, and pro-apoptotic and anti-apoptotic genes and proteins expression analysis using real-time PCR and Western Blotting methods.
Taking into account the variability of the composition of PJ related to biodiversity and seasonal changes, even the studies on fresh juices alone are a huge challenge for many research groups. Nevertheless, it would also be worth finding the reason for the favorable ratio of cytotoxicity of DPJ against cancer cells and against normal cells. Is it a result of changes in the content of individual bioactive substances, or is it an artifact of the deproteinization process itself? The industrial deproteinization process may result in the introduction of additional substances, sometimes undesirable from a nutritional point of view, which may act as some kind of adjuvant enhancing the potential cytotoxic effects of DPJ.
5. Conclusions
Our study proved that solanine and chaconine reveal cytotoxicity against cancer AGS, Hs746T, HT-29, Caco-2, and normal hIEC-6, CCD 481 CoN cell lines. In all cell cultures tested, chaconine was characterized by higher cytotoxicity than solanine, which was expressed by approximately twice lower IC50 values. In contrast, ferulic, caffeic, and chlorogenic acids at concentrations up to 200 µM do not show cytotoxicity to the cell lines used in the study.
Furthermore, fresh PJ and the products of its processing, subjected to gastric digestion, were shown to reveal cytotoxicity against stomach cancer AGS and Hs746T cells. Gastrointestinally-digested products revealed cytotoxicity against intestinal cancer HT-29 and Caco-2 cells and normal CCD 481 CoN and hIEC-6 cells. That cytotoxicity was non-linearly related to the presence of GAs in the analyzed products. The lowest cytotoxicity was found for juices derived from three edible potato varieties, the highest deproteinized potato juice, and the side stream of feed protein preparation production. However, statistical analysis showed that when considering the effectiveness of the mass unit of total GAs, the most effective are juices from edible varieties of potatoes containing less GAs and DPJ rich in GAs. Moreover, the cytotoxicity of a mass unit of total GAs contained in PJ and the products of its processing is higher than the cytotoxicity of chaconine. This proves synergy in the cytotoxic activity of biologically active compounds contained in PJ products.